NCT00000442View on ClinicalTrials.gov

Naltrexone for Relapse Prevention

PHASE4CompletedINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2002

Conditions

Alcoholism

Interventions

DRUG

naltrexone (Revia)

Trial Locations (1)

19103

Department of Psychiatry, University of Pennsylvania, Philadelphia

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

UConn Health

OTHER